The results of this study highlight the potential of this bacterium as a probiotic treatment for CDI. “
“We explored the physiological and metabolic effects of different carbon sources (glucose, fructose, and glucose/fructose mixture) in phosphoglucose isomerase (pgi) knockout Escherichia coli mutant producing shikimic acid (SA). It was observed that the pgi− mutant grown on glucose exhibited significantly lower cell growth compared with the pgi+ strain

and its mixed glucose/fructose fermentation grew well. Interestingly, when fructose was used as a carbon source, the pgi− mutant showed the enhanced SA production compared with the pgi+ strain. In silico analysis of a genome-scale E. coli model Trichostatin A was then conducted to characterize the cellular metabolism and quantify NAPDH regeneration, which allowed us to understand such experimentally observed attenuated cell growth and enhanced SA production in glucose- and fructose-consuming pgi− mutant, respectively with respect to cofactor regeneration. Shikimic acid (SA) is a key chiral starting compound for the synthesis of neuraminidase inhibitors, marketed as Tamiflu®, which can be used to treat

influenza (Kim et al., 1997). The conventional method of producing SA from plants such RO4929097 datasheet as Illicium anistatum is typically low-yield, cumbersome and costly. Thus, researchers have studied microbial systems, such as Escherichia coli, as an alternative SA producer, where it can be synthesized via aromatic amino acid biosynthetic pathways (Davis, 1950). However, microbial Aspartate SA biosynthesis is substantially limited by in vivo availability of both d-erythrose-4-phosphate (E4P) and phosphoenolpyruvate that condensate to form 3-deoxy-d-arabino-heptulosonate-7-phosphate, leading toward SA after further NADPH-dependent metabolic steps (Fig. 1). Thus, various genetic strategies have been applied to increase in vivo

E4P and phosphoenolpyruvate pools via potentially enhanced cofactor regeneration (Kramer et al., 2003). The perturbation of the reaction catalyzed by phosphoglucose isomerase (PGI), located at the junction of Embden-Meyerhof-Parnas and pentose phosphate (PP) pathways, can dramatically alter cellular metabolism, particularly NADPH regeneration, from glucose as a carbon source (Fig. 1). Previous studies (Fraenkel & Levisohn, 1967; Hua et al., 2003) have shown that deletion of the pgi gene can lead to physiological and metabolic changes depending on the carbon source. Hence, in this study, we examined this interesting cellular behavior and fermentation characteristics of E. coli pgi− mutant with respect to SA production in the presence of glucose, fructose, or a glucose/fructose mixture as the carbon source. Based on the observed phenotype, the corresponding metabolic states of E.